Agalimmune's Acquisition

Agalimmune was acquired by BioLineRx on March 23, 2017.

Agalimmune is a biopharmaceutical company with an innovative anti-cancer technology for the treatment of patients with solid tumors. The Company's vision is to harness the power of the cancer patient'…

Articles about Agalimmune's Acquisition: